Skip to main content

Table 2 Matched cohort study.

From: Design of cohort studies in chronic diseases using routinely collected databases when a prescription is used as surrogate outcome

 

Odds ratio

95% confidence interval

P

Statin exposure

1.064

0.879

1.288

0.523

Fibrate

1.167

0.905

1.504

0.233

Ace inhibitors

0.961

0.911

1.014

0.144

Digoxin

1.005

0.919

1.098

0.92

Warfarin

1.078

0.951

1.223

0.242

Loop diuretic

1.01

0.888

1.149

0.879

NSAID

1.014

0.976

1.054

0.472

OS

2.158

1.881

2.477

<0.001

Thiazide

0.98

0.909

1.058

0.612

DMARD

1.083

1.042

1.126

<0.001

Potassium sparing

1.029

0.905

1.169

0.665

Beta blockers

1.029

0.958

1.105

0.433

Angiotensine

1.071

0.948

1.211

0.268

Clopidogrel

1.091

0.888

1.341

0.408

Hyperlipidemia

0.805

0.607

1.067

0.131

Transient Ischaemic attack

1.153

0.706

1.882

0.569

Osteoarthritis

1.2

0.924

1.558

0.172

Angina

0.918

0.707

1.192

0.522

Asthma COPD

1.638

1.263

2.124

<0.001

Myocardial infarction

1.299

0.853

1.98

0.223

Diabetes

0.455

0.271

0.764

0.003

Hypertersion

1.147

0.485

2.714

0.754

Stroke

0.744

0.502

1.101

0.139

Peptic Ulcer

0.81

0.408

1.608

0.546

Cerebral Heamorragea

1.098

0.509

2.367

0.811

Heart failure

0.569

0.172

1.889

0.357

  1. Results from the conditional logistic regression adjusted for morbities and medications before the index date
Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us